Anteris Technologies Global Corp. filed a Form S-1 registration statement for an initial public offering on 2024-11-22. It has amended it 1 time. It filed its final prospectus on 2024-12-13, at a public offering price of $6.00 per share. Each fact below is quoted from the filing named with it.
What the filings say
Listing
Our Common Stock is listed on the Nasdaq Global Market (“Nasdaq”) under the symbol “AVR.” Our CDIs trade on the Australian Securities Exchange (the “ASX”) under the symbol “AVR.” On November 25, 2025, the closing price for our Common Stock on Nasdaq was $3.85 per share.From the S-1 filed 2025-11-26
Shares offered
We are offering 14,800,000 shares of our Common Stock to be sold in this offering at an initial public offering price of $6.00 per share.From the 424B4 filed 2024-12-13
Offering price
We are offering 14,800,000 shares of our Common Stock to be sold in this offering at an initial public offering price of $6.00 per share.From the 424B4 filed 2024-12-13
Use of proceeds
Unless we inform you otherwise in a prospectus supplement or free writing prospectus, we expect to use the net proceeds from the exercise of such Warrants primarily for the ongoing development of our DurAVR ® THV system, the preparation and enrollment of the PARADIGM Trial of DurAVR ® THV system for treating severe aortic stenosis, and ongoing R&D for v2vmedtech, with the remaining for working capital and other general corporate purposes determined from time to time.From the S-1 filed 2025-11-26
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2024-11-22 | Registration statement filed | S-1 |
| 2024-12-09 | Registration statement amended | S-1/A |
| 2024-12-13 | Final prospectus filed: the offering is priced | 424B4 |
| 2025-11-26 | Registration statement filed | S-1 |
Tools for this story
Each opens in a new tab, filled in for Anteris Technologies Global Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.